Biohaven Ltd. will present an investor presentation detailing its ongoing and planned trials for various development programs, including troriluzole, taldefgrobep ...

Pomerantz LLP is investigating claims on behalf of investors of  Laser Photonics Corporation ("Laser Photonics" or the "Company") .  Such investors are advised to contact Danielle Peyton at ...

Pomerantz LLP is investigating claims on behalf of investors of  Eos Energy Enterprises, Inc. ("Eos" or the "Company") . Such investors are advised to contact Danielle Peyton at ...

We recently published a list of Jim Cramer’s Thoughts on These 10 Stocks. In this article, we are going to take a look at ...

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

A quality improvement strategy can improve electronic health record-based screening for depression and anxiety in people with ...

PFE stock offers high dividend yields supported by cost optimizations and R&D. Discover its potential amid COVID-19 sales ...

The Spinocerebellar Ataxia pipeline is advancing fast as troriluzole nears FDA nod and rivals race with gene and stem cell therapies to seize market edge. Disease modification in spinocerebellar ...

Not content with a $1.2 billion licensing deal for Biohaven Pharma's oral migraine therapy rimegepant, Pfizer has just offered to buy the company outright – for a cool $11.6 billion. Pfizer's ...

Earlier today, Pfizer (NYSE:PFE) announced it agreed to acquire Biohaven Pharmaceutical (NYSE:BHVN) in a cash-and-stock $11.6... Pre-Open Stock Movers 05/10: Biohaven Surges on Takeover ...

A colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...